You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 3, March 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Control of Early Postoperative Pain With Bupivacaine in Adult Local Tonsillectomy

LCDR Scott R. Schoem, MC, USNR; LCDR G. Lee Watkins, MC, USNR; LCDR Jeffrey J. Kuhn, MC, USNR; LCDR John F. Alburger, MC, USNR; LCDR Kun Z. Kim, MC, USNR; CAPT David H. Thompson, MC, USN

Arch Otolaryngol Head Neck Surg. 1993;119(3):292-293.


Abstract

• Early postoperative pain following tonsillectomy remains a significant obstacle to speedy recovery and smooth convalescence. Inadequate analgesia causes poor oral intake and occasionally requires overnight hospitalization in sameday surgery practices. Although several otolaryngologists anecdotally support intraoperative infiltration with long-acting anesthetic agents for postoperative pain control, to our knowledge, no previous study confirms this claim. In a prior investigation, we found no difference between bupivacaine hydrochloride and saline placebo in pediatric patients undergoing tonsillectomy. In this trial, we performed a similar study in an adult population. Fifty-one patients undergoing tonsillectomy with local anesthesia were randomized into bupivacaine or saline placebo groups. patients provided the following data: (1) pain level; (2) oral intake; (3) number of pain medication doses; and (4) level of pain on jaw opening, all at 10 hours postoperatively. Bupivacaine administration resulted in no adverse effects. No difference was noted in pain level, amount of oral intake, or pain on full jaw opening. Bupivacaine group patients received fewer though not statistically significant doses of pain medication than placebo group patients. We conclude that bupivacaine is a safe medication but offers no advantage in the control of early postoperative pain in adult patients undergoing local tonsillectomy.

(Arch Otolaryngol Head Neck Surg. 1993;119:292-293)



Author Affiliations

From the Department of Otolaryngology—Head and Neck Surgery, National Naval Medical Center, Bethesda, Md.


Footnotes

Accepted for publication October 30, 1992.

Reprint requests to Department of Otolaryngology—Head and Neck Surgery, National Naval Medical Center, Bethesda, MD 20889-5000 (Dr Schoem).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Preincisional Bupivacaine in Posttonsillectomy Pain Relief: A Randomized Prospective Study
Vasan et al.
Arch Otolaryngol Head Neck Surg 2002;128:145-149.
ABSTRACT | FULL TEXT  

A Micromechanical Analysis of the Radial Elastic Response Associated with Slender Reinforcing Elements within a Matrix
Cox and Yu
Journal of Composite Materials 1999;33:2161-2192.
ABSTRACT  

Assessment of Postoperative Pain After Laryngeal Surgery for Cancer
Mom et al.
Arch Otolaryngol Head Neck Surg 1998;124:794-798.
ABSTRACT | FULL TEXT  

Use of Intraoperative Corticosteroids in Pediatric Tonsillectomy
Ohlms and Wilder
Arch Otolaryngol Head Neck Surg 1995;121:737-742.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.